2 studies found for:    23633407 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed An Open-Label, Randomized Phase I Study in Healthy Adults of the Safety and Immunogenicity of Prime-Boost Intervals With Monovalent Influenza Subunit Virion (H5N1) Vaccine, A/Indonesia/05/2005 (Sanofi Pasteur, Inc.) Administered Alone or Following Re...
Condition: Influenza A Virus, H5N1 Subtype
Interventions: Biological: VRC-AVIDNA036-00-VP;   Biological: Monovalent Influenza Subunit Virion (Inactive H5N1) Vaccine
2 Active, not recruiting H7 Influenza Prime-Boost Regimens in Healthy Adults: Recombinant H7 DNA Plasmid Vaccine, VRC-FLUDNA071-00-VP, Administered Alone or With Monovalent Influenza Subunit Virion H7N9 Vaccine (MIV) as Prime With MIV Boost Compared to MIV Prime With MIV Boo...
Condition: Influenza
Interventions: Biological: A/Shanghai/02/2013 (H7N9) MIV;   Biological: VRC-FLUDNA071-00-VP

Indicates status has not been verified in more than two years